Intelliject Inc is categorized under Commercial Medical Research in Richmond, VA and active since 2004.
Intelliject Inc was established in 2004, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 6231100 by the NAICS.
If you are seeking more information, feel free to contact Spencer Williamson, President at the company’s single location by writing to 111 Virginia St # 405, Richmond, Virginia VA 23219 or by phoning (804) 545-6360. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Intelliject Inc |
Contact Person: | Spencer Williamson, President |
Address: | 111 Virginia St # 405, Richmond, Virginia 23219 |
Phone Number: | (804) 545-6360 |
Website Address: | intelliject.com |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 2004 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Commercial Medical Research |
SIC Code: | 8731 |
NAICS Code: | 6231100 |
Share This Business: |
Intelliject Inc was started in 2004 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 6231100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Spencer Williamson, President for inquiries that concern Intelliject Inc by calling the company number (804) 545-6360, as your correspondence is most welcome. Additionally, the physical location of the single location of Intelliject Inc can be found at the coordinates 37.53407,-77.43327 as well as the street address 111 Virginia St # 405 in Richmond, Virginia 23219.
For its online presence, you may visit Intelliject Inc’s website at intelliject.com and engage with its social media outlets through on Twitter and on Facebook.